The effect of frusemide on oxytocin-induced contractions of the rat myometrium

Exp Physiol. 1994 Sep;79(5):661-7. doi: 10.1113/expphysiol.1994.sp003798.

Abstract

Oxytocin-induced contractions of isolated strips of oestradiol-treated rat myometrium were found to be affected by exposure to the diuretic frusemide. At a concentration of 20 microM. frusemide transiently increased the force of contraction over a period of approximately 10 min. After this time there was a progressive fall in contractile force. At a higher concentration of 200 microM, only the progressive fall in force was seen until contractions were completely abolished. Frusemide has been reported to increase the activity of cAMP-phosphodiesterase in tissue extracts from oestradiol-treated rat myometrium. Therefore, the changes in contraction due to exposure to frusemide may be a reflection of the changes in intracellular cAMP resulting from a stimulation of cAMP-phosphodiesterase activity. In support of this idea, addition of dibutyryl cAMP was found to partially restore contractions after frusemide treatment. These data suggest that frusemide may be a useful tool in the manipulation of tissue cAMP levels in order to determine the different roles of cAMP in the oestradiol-treated rat myometrium.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bucladesine / pharmacology
  • Cyclic AMP / metabolism
  • Female
  • Furosemide / pharmacology*
  • In Vitro Techniques
  • Myometrium / drug effects*
  • Myometrium / physiology
  • Oxytocin / pharmacology*
  • Rats
  • Rats, Wistar
  • Uterine Contraction / drug effects*

Substances

  • Oxytocin
  • Bucladesine
  • Furosemide
  • Cyclic AMP